The revenue of ADMA BIOLOGICS, INC. over the past 10 years
Chart ADMA BIOLOGICS, INC.: revenue, fiscal 2016–2025 Open the chart →ADMA BIOLOGICS, INC. reported revenue of $510.17M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $10.66M — up 4685% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2017: up 113%, from $10.66M to $22.76M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $510.17M |
| 2024ended Dec 31, 2024 | $426.45M |
| 2023ended Dec 31, 2023 | $258.21M |
| 2022ended Dec 31, 2022 | $154.08M |
| 2021ended Dec 31, 2021 | $80.94M |
| 2020ended Dec 31, 2020 | $42.22M |
| 2019ended Dec 31, 2019 | $29.35M |
| 2018ended Dec 31, 2018 | $16.99M |
| 2017ended Dec 31, 2017 | $22.76M |
| 2016ended Dec 31, 2016 | $10.66M |
Fiscal years as ADMA BIOLOGICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADMA BIOLOGICS, INC.
- The profitability of ADMA BIOLOGICS, INC.
- The cash flow of ADMA BIOLOGICS, INC.
- The debt of ADMA BIOLOGICS, INC.
- All of ADMA BIOLOGICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what ADMA BIOLOGICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.